Sopharma AD
Pharmaceutical producer of Rx, OTC, and plant-based medicines for international markets.
SFA | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG11SOSOBT18
- LEI:
- 097900BGGW0000048796
- Country:
- Bulgaria
- Address:
- ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София
- Website:
- https://www.sopharmagroup.com/
- Sector:
- Manufacturing
Description
Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-06-07 14:22 |
Insider trading disclosure of June, 4 2018 received by Donev Investments Holdi…
|
Polish | 124.2 KB | ||
| 2018-06-07 07:59 |
Insider trading disclosure of June, 6 2018 received by Ognian Donev
|
Polish | 98.4 KB | ||
| 2018-06-06 08:43 |
Notification by Ognian Donev
|
Polish | 98.5 KB | ||
| 2018-06-05 13:14 |
Sales revenues for May 2018
|
Polish | 56.1 KB | ||
| 2018-06-05 13:05 |
ACQUISITION OF OWN SHARES
|
Polish | 10.4 KB | ||
| 2018-06-05 07:43 |
Notification by Ognian Donev
|
Polish | 100.1 KB | ||
| 2018-06-04 13:04 |
Notification
|
Polish | 9.3 KB | ||
| 2018-06-04 07:40 |
Insider trading disclosure of June, 1 2018 received by Ognian Donev
|
Polish | 106.4 KB | ||
| 2018-05-30 13:23 |
Interim condensed consolidated financial statements for the three-month period …
|
Polish | 2.4 MB | ||
| 2018-05-15 14:06 |
Termination of the previous and start a new transformation procedure through th…
|
Polish | 9.7 KB | ||
| 2018-05-09 13:35 |
Sales revenues for April 2018
|
Polish | 56.0 KB | ||
| 2018-05-03 13:50 |
Invitation and materials for the General meeting of shareholders of Sopharma AD
|
Polish | 3.8 MB | ||
| 2018-05-02 13:22 |
Issued refusal by the Registry Agency on the transformation through merger betw…
|
Polish | 56.5 KB | ||
| 2018-04-27 17:40 |
Annual audited consolidated financial report for 2017
|
Polish | 14.4 MB | ||
| 2018-04-27 13:53 |
Financial report for the period ending 31.03.2018
|
Polish | 2.5 MB |
Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sopharma AD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sopharma AD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
